Clinical Trial Update: Study of the Safety and Tolerability of Oral Capsule Form of PCI-24781 in Advanced Cancer Patients [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety and tolerability of an oral capsule form of PCI-24781 in adults with advanced cancers, and the trial status is completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Hodgkin Lymphoma
• Multiple Myeloma
• Non-hodgkin Lymphoma

Drugs mentioned

• PCI-24781 (PCI-24781)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Neoplasms by Site, Lymphoma, Non-hodgkin | Phase 1 | Status: COMPLETED